Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
The Annals of Thoracic Surgery
|
April 23, 2016
A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032)
Michael S Kent, Sumithra J Mandrekar, Rodney Landreneau, et al.
Cancer Chemotherapy and Pharmacology
|
June 10, 2006
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies
Cynthia Ma, Sumithra J Mandrekar, Steven R Alberts, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 1, 2007
Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancer
Jann N Sarkaria, Paul Schwingler, Steven E Schild, et al.
Investigational New Drugs
|
October 12, 2013
UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine
Matthew P Goetz, Heidi A McKean, Joel M Reid, et al.
Journal of the National Cancer Institute. Monographs
|
February 24, 2025
Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP)
Anna C Snavely, Heather J Gunn, Ju-Whei Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2019
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study
Erin L Schenk, Sumithra J Mandrekar, Grace K Dy, et al.
JAMA
|
April 17, 2019
Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial
Terence T Sio, Jennifer G Le-Rademacher, James L Leenstra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2014
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer
Hiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Plos Medicine
|
November 23, 2013
A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient care
Jennifer L Ridgeway, Timothy J Beebe, Christopher G Chute, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial
Hiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
The Annals of Thoracic Surgery
|
April 23, 2016
A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032)
Michael S Kent, Sumithra J Mandrekar, Rodney Landreneau, et al.
Cancer Chemotherapy and Pharmacology
|
June 10, 2006
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies
Cynthia Ma, Sumithra J Mandrekar, Steven R Alberts, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 1, 2007
Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancer
Jann N Sarkaria, Paul Schwingler, Steven E Schild, et al.
Investigational New Drugs
|
October 12, 2013
UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine
Matthew P Goetz, Heidi A McKean, Joel M Reid, et al.
Journal of the National Cancer Institute. Monographs
|
February 24, 2025
Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP)
Anna C Snavely, Heather J Gunn, Ju-Whei Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2019
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study
Erin L Schenk, Sumithra J Mandrekar, Grace K Dy, et al.
JAMA
|
April 17, 2019
Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial
Terence T Sio, Jennifer G Le-Rademacher, James L Leenstra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2014
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer
Hiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Plos Medicine
|
November 23, 2013
A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient care
Jennifer L Ridgeway, Timothy J Beebe, Christopher G Chute, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial
Hiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Page
of 4